-
Human Gene Editing Receives Science Panel’s Support
The New York Times | Pressed by controversial, advancing technology, an influential committee laid out the conditions under which human embryos might be engineered with heritable traits.
Feb 14, 2017
-
Bionano Genomics Announces Global Launch Of Saphyr
Bio-IT World Brief | Bionano Genomics today announced the global commercial launch of Saphyr, its newest and most advanced system for genome mapping.
Feb 13, 2017
-
Illumina Welcomes New Startups To Its Accelerator Program
Bio-IT World Brief | Illumina announced today that it has chosen three new startups to join its accelerator program, which provides investment capital and other resources to early-stage companies developing new genomic technologies and applications.
Feb 10, 2017
-
A Call For Academic Drug Companies
In The Pipeline | Derek Lowe, in his blog for Science Translational Medicine, offers his thoughts on the question, "How Much Longer Will We Put Up With $100,000 Cancer Drugs?"
Feb 10, 2017
-
MyHeritage Announces Yaniv Erlich As New Chief Science Officer
Bio-IT World Brief | Yaniv Erlich is joining Israeli online genealogy platform company, MyHeritage, as Chief Science Officer.
Feb 9, 2017
-
Chan Zuckerberg Biohub Names Investigators, Builds Collaborative Culture
Bio-IT World The Chan Zuckerberg Biohub has named its first cohort of 47 investigators from the University of California, Berkeley, Stanford University and the University of California, San Francisco.
Feb 8, 2017
-
Align Biopharma Provides Easier Connection To Healthcare Professionals
Bio-IT World | Six technology leaders have come together to create Align Biopharma, a new industry standards group aiming to ease digital engagement challenges for member companies and their users.
Feb 8, 2017
-
FDA Proposal On Biotech Drugs Sparks Criticism
TheHill | The FDA wants to give biotech drugs more distinct names, but some drugmakers and agencies aren't on board.
Feb 7, 2017
-
Malin Announces Acquisition Of Artizan Biosciences Shareholdings
Bio-IT World Brief | Malin today announced that it has acquired a 32% shareholding of Artizan Biosciences.
Feb 6, 2017
